These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5149135)

  • 21. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
    Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
    Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Glycerin ester of higher fatty acids as pharmaceutic aids. 6. Release of an imbedded drug from tablets containing higher fatty acids and their esters].
    Chalabala M; Starha L
    Pharmazie; 1970 Sep; 25(9):535-8. PubMed ID: 5486680
    [No Abstract]   [Full Text] [Related]  

  • 23. [Coating tablets with high molecular weight film-forming compounds. II. Obtaining a fast dissolving ethyl cellulose coating].
    Daragan AG
    Aptechn Delo; 1966; 15(4):10-4. PubMed ID: 5990574
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.
    Kranz H; Guthmann C; Wagner T; Lipp R; Reinhard J
    Eur J Pharm Sci; 2005 Sep; 26(1):47-53. PubMed ID: 15953712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the tenside content and pressing power on the capillarity of compressed drugs].
    Hüttenrauch R; Zahn U
    Pharmazie; 1974 Dec; 29(12):790. PubMed ID: 4460009
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes.
    Jeong SH; Park K
    Int J Pharm; 2008 Apr; 353(1-2):195-204. PubMed ID: 18164882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
    van Veen B; Pajander J; Zuurman K; Lappalainen R; Poso A; Frijlink HW; Ketolainen J
    Eur J Pharm Biopharm; 2005 Oct; 61(3):149-57. PubMed ID: 16005196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of pharmaceutical availability of salicylic acid from tablets containing amphoteric surfactants.
    Bialik W; Jaworski E
    Pharmazie; 1990 May; 45(5):376-7. PubMed ID: 2395904
    [No Abstract]   [Full Text] [Related]  

  • 29. [Conditions of manufacture of 10% salicylic acid ointment in Vaseline which is effective for 6 months].
    Gruntová Z; Civánová L
    Cesk Farm; 1979 Dec; 28(9-10):387-90. PubMed ID: 550932
    [No Abstract]   [Full Text] [Related]  

  • 30. [Advances in pharmaceutical technology in years 1966-1967. I. General works, pharmaceutic aids, manufacturing processes, packing technic].
    Chalabala M; Malý J; Burelová A; Starha L; Heliová M; Rak J; Rehula A
    Cesk Farm; 1968 Oct; 17(8):392-8. PubMed ID: 4888355
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of tablets. 3. Influence of non-ionic surfactants with ester linkage on qualities of sulfanilamide grains and tablets].
    Duchêne D; Djiane A; Puisieux F
    Ann Pharm Fr; 1970 Apr; 28(4):289-98. PubMed ID: 5430303
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photoimages and the release characteristics of lipophilic matrix tablets containing highly water-soluble potassium citrate with high drug loadings.
    Cao QR; Kim TW; Lee BJ
    Int J Pharm; 2007 Jul; 339(1-2):19-24. PubMed ID: 17532156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of surfactants of Rofam type on properties of piroxicam tablets.
    Szulc-Musioł B; Jankowski A
    Acta Pol Pharm; 2009; 66(2):195-200. PubMed ID: 19719055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disintegration and dissolution studies on amylobarbitone tablets.
    Surén G
    Acta Pharm Suec; 1970 Nov; 7(5):483-90. PubMed ID: 5488739
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of tensides on some properties of tablets. I. Tablets containing hydrophobic substances].
    Chodkowska-Granicka B; Krówczyński L
    Acta Pol Pharm; 1968 Jun; 25(3):299-305. PubMed ID: 5697611
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of disubstituted calcium phosphate and Tween-80 on the disintegration and rate of release of active substances from tablets].
    Amirov BN; Belozerova OP
    Farmatsiia; 1973; 22(4):18-22. PubMed ID: 4754239
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of tablets. 10. Influence of non-ionic surfactants on the compressibility of sulfanilamide].
    Duchêne D; Terrier JL; Clerc J; Puisieux F
    Ann Pharm Fr; 1973; 31(9):583-92. PubMed ID: 4793701
    [No Abstract]   [Full Text] [Related]  

  • 39. [Optimization of the technology and a biopharmaceutic study of mefenamic acid suppositories].
    Golovkin VA; Lukash EP; Fadeicheva AG; Groshovyĭ TA; Mokhort NA
    Farmatsiia; 1978; 27(4):16-9. PubMed ID: 689174
    [No Abstract]   [Full Text] [Related]  

  • 40. [Influence of adjuvants on the speed of dissolution and stability of acetylsalicylic acid in tablets. I. Effects of some disintegrating agents].
    Cid E; Jaminet F
    J Pharm Belg; 1971; 26(1):38-48. PubMed ID: 5559275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.